Western Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Western Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $14,749 - $17,659	43 Added 4.76%	947 $385,000
Q3 2023 Nov 07, 2023	SELL	$338.18 - $362.46 $21,305 - $22,834	-63 Reduced 6.51%	904 $314,000
Q2 2023 Aug 30, 2023	BUY	$314.42 - $351.91 $304,044 - $340,296	967 New	967 $340,000
Q3 2022 Nov 04, 2022	BUY	$273.83 - $305.53 $197,705 - $220,592	722 New	722 $208,000
Q2 2022 Jul 18, 2022	SELL	$234.96 - $292.55 $232,375 - $289,331	-989 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $218,984 - $258,099	989 New	989 $257,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Western Wealth Management, LLC with notifications on news.